Actionable Opportunities in Special Situations: Spinoffs, Bankruptcy, Restructurings


OncoSec Medical (ONCS) announces reverse stock split ahead of NASDAQ uplisting

OncoSec Medical (OTCQB: ONCS), a company developing DNA-based intratumoral cancer immunotherapies, announced that its Board of Directors has approved a 1-for-20 reverse stock split of the company’s authorized, issued, and outstanding common stock in preparation for its proposed listing of its common stock on the NASDAQ Capital Market. Source

Get Documents via Email

Document search By Category